PKM and colorectal carcinoma: It was found that oxaliplatin-resistant CRC cells-derived exosomal circRNA ciRS-122 was delivered to sensitive cells, which enhanced glycolysis and chemoresistance in sensitive cells via miR-122/PKM2 signaling axis [292].